MENU
FEB 24, 2021 12:00 PM PST

Deep Mechanistic profiling of immune oncology drug combinations in cancer patients with CIVO intratumoral micro-dosing and NanoString's GeoMx® Digital Spatial Profiler

Sponsored by: NanoString Technologies
C.E. Credits: Florida CE P.A.C.E. CE
Speakers

Abstract

With an introduction by Sarah Warren, the Senior Director of Translational Science, this webinar will open by providing a brief technology overview of NanoString Technologies. Dr. Warren will give an overview of the NanoString digital spatial profiling platform, GeoMx® DSP, along with curated gene expression panels that focus on all aspects of the biomarker and drug development continuums. Following the introduction will be speaker Jason Frazier from Presage Biosciences. Despite over four thousand clinical trials designed to investigate combinations of various anti-cancer agents with PD1/PD-L1 targeting checkpoint inhibitors (CPI), few have demonstrated significant clinical improvement over CPI alone.  This suggests the need for far greater mechanistic understanding of tumor cell and microenvironment response to drug exposure to guide development of complex (≥ 3 drug) combination treatments.  Here, we show how an approach based on two technologies, the Presage Comparative In Vivo Oncology (CIVO) Platform and the Nanostring GeoMx Digital Spatial Profiler (GeoMx DSP), can provide information on the activity of drugs in vivo at the cellular level, delineate the cellular targets and mechanisms of action, and provide a path to rapid identification of effective drug combinations, all in the most authentic and relevant context, the human cancer patient. The CIVO platform enables trackable multiplexed intratumoral delivery of spatially restricted micro-dosed drugs, either as single agents or in combinations, allowing simultaneous evaluation of the localized tumor response to multiple different drugs and drug combinations in the native tumor microenvironment (TME).  By combining GeoMx digital spatial profiling with multiplex CIVO micro-dosing in human sarcomas, we evaluated over 1800 gene transcripts per site of drug exposure and measured drug-, cell-, and region-specific transcriptional responses in individual patient tumors.  We showed T-cell specific activation following exposure to localized combination of aldesleukin (recombinant IL-2) and nivolumab (anti-PD1).  Importantly, we show how such events indicating T-cell activation may be dampened by feedback loops involving immune suppressive responses such as elevation of IDO-1 in the non T-cell compartment of the TME. Ultimately, the capability to perform high-plex spatial analysis across multiplex micro-dosed patient tumors will allow us to better understand the mechanism of action of drugs and responses in different compartments of the TME and evaluate the inter-individual variation in the responses to many different IO drugs and drug candidates.

Learning Objectives:

1. Understand some key bulk gene expression tools available for oncology biomarker and drug development research

2. Understand the concept of spatially resolved transcriptomics- Nature’s 2020 Method of the Year

3. Understand how two synergistic platforms were used to profile IO drug combinations in a real world setting at a biotech company


Show Resources
You May Also Like
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
JUL 15, 2021 9:00 AM PDT
JUL 15, 2021 9:00 AM PDT
Date: July 15, 2021 Time: 9:00am (PDT), 12:00pm (EDT) The Pisces workflow robust, easy-to-use, end-to-end multi-omics solution for highly multiplexed targeted Spatial RNA analysis. VeranomeB...
JUL 15, 2021 8:00 AM PDT
C.E. CREDITS
JUL 15, 2021 8:00 AM PDT
Date: July 15, 2021 Time: 8:00am (PDT), 11:00am (EDT) High dimensional full spectrum flow cytometry grants unprecedented access to previously unattainable parameters in cellular biology. Flu...
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
NOV 17, 2021 8:00 AM PST
C.E. CREDITS
NOV 17, 2021 8:00 AM PST
Date: November 17, 2021 Time: 8:00am (PDT), 11:00am (EDT) From waste disposal to promising biomarkers and therapeutic agents, exosomes and other extracellular vesicles are valuable in resear...
Loading Comments...
Show Resources